RESISTANCE TO ATRACURIUM IN RATS WITH EXPERIMENTAL INFLAMMATION - ROLE OF PROTEIN-BINDING

The influence of altered protein binding on the neuromuscular effect of atracurium has been studied in rats with experimental inflammation induced by subcutaneous injection of turpentine oil. Doses of atracurium ranging from 0.15 to 1.5 mg . kg(-1) were administered to control (n = 30) and to experimental inflammation induced rats (n = 30). Neuromuscular transmission was monitored by recording the twitch tension of the tibialis-anterior muscle elicited by stimulation of the sciatic nerve. Three effect parameters were recorded: (i) intensity of the effect, measured as percentage depression of baseline twitch tension, (ii) duration of drug action (min) and (iii) recovery time (min). The dose-intensity of the effect relationship was modelled using a simoid E(max) model. The ED(50) (effective dose eliciting 50% of the maximum effect) was significantly increased (P<0.01) in the inflammation group as compared to the control group (0.94 vs. 0.68 mg . kg(-1)). This change was reflected in a shift of the dose-response curve io the right in the pretreated rats. For equipotent doses ED(95) (defined as the effective dose eliciting 95% of maximum effect), no differences were found in recovery time and duration of action between the two groups of rats. Mucoproteins levels (index of alpha(1)-acid glycoprotein (AAG)) and protein binding were significantly increased in rats with experimental inflammation as compared to control rats. Based on these results, altered serum protein binding of atracurium appears to be responsible, at least in part, for the resistance to atracurium.